<DOC>
	<DOCNO>NCT00889447</DOCNO>
	<brief_summary>This research do study mechanism progression COPD develop treatment . The investigator present study identify people age 40 old mild moderate COPD qualify study include database . The study include establish screen evaluation characterization follow two study : - Emphysema Progression COPD- Losartan 's Effects Airway Parameters - NA_00009980 - Sleep-Related Physiology Inflammation Chronic Obstructive Pulmonary Disease - NA_00001771</brief_summary>
	<brief_title>Screening Evaluation Studies Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description>This program recruit screen participant clinical trial detail observational study COPD . There intervention comparative result publish study .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Age 40 year old , either sex Mild moderate COPD ( FEV1/FVC ratio ≤ 0.70 , FEV1 3070 % predict , DLCO ≥35 % predict ) On stable maintenance therapy 2 month Current former smoker ( patient report least 10 packyear history ) Ability understand willingness sign consent document COPD exacerbation require treatment within past 6 week Untreated arterial hypertension ( systolic blood pressure &gt; 140 mm Hg , diastolic blood pressure &gt; 90 mm Hg ) Decompensated heart failure Myocardial infarction within past 3 month ever Evidence interstitial , occupational chronic infectious lung disease Renal dysfunction Supplemental oxygen &gt; 2L/m rest Failure keep screening appointment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Chronic Obstructive Pulmonary disease ( COPD )</keyword>
</DOC>